Fosmetpantotenate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameFosmetpantotenate
Drug Alias NameVA101M0K2F (UNII code)RE-024
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsPantothenate Kinase-Associated Neurodegeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[9] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTravere Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTravere Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsPantothenate Kinase-Associated Neurodegeneration

Other Information

ATC CodeN/A
Related LinksN/A